GhosseinR. 2009. Update to the College of American Pathologists reporting on thyroid carcinomas. Head Neck Pathol, 3:86–93.
2.
RosaiJ, CarcangiuML, DelellisRA, Sobrinho-SimoesM. 2000. Recommendations for the reporting of thyroid carcinomas. Association of Directors of Anatomic and Surgical Pathology. Hum Pathol, 31:1199–1201.
3.
KahnC, SimonellaL, SywakM, BoyagesS, O'ConnellD. 2012. Post surgical pathology reporting of thyroid cancer in New South Wales, Australia. Thyroid, 22:604–610.
4.
DettmerM, SchmittA, SteinertH, HaldemannA, MeiliA, MochH, KomminothP, PerrenA. 2011. Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed?Am J Surg Pathol, 35:1866–1872.
5.
MoonHJ, KimEK, ChungWY, YoonJH, KwakJY. 2011. Minimal extra-thyroidal extension in patients with papillary thyroid microcarcinoma: is it a real prognostic factor?Ann Surg Oncol, 18:1916–1923.
6.
MeteO, RotsteinL, AsaSL. 2010. Controversies in thyroid pathology; thyroid capsule invasion and extra-thyroidal extension. Ann Surg Oncol, 17:386–391.
7.
MeteO, AsaSL. 2011. Pathological definition and clinical significance of vascular invasion in thyroid carcinoma of follicular epithelial derivation. Mod Pathol, 24:1545–1552.
8.
BagariaSP, RayPS, WangJ, KropchoL, ChungA, SimMS, ShamonkiJM, MartinoS, CuiX, GiulianoAE. 2012. Prognostic value of basal phenotype in HER-2-overexpressing breast cancer. Ann Surg Oncol, 19:935–940.
9.
SchlechtNF, Brandwein-GenslerM, NuovaGL, LiM, DunneA, KawachiN, SmithRV, BurkRD, PrystowskyMB. 2011. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Mod Pathol, 24:1295–1305.
10.
LudoviniV, BianoconiF, PistolaL, MinottiV, ChiariR, ColellaR, BellezzaG, TofanettiFR, SiggillinoA, BaldelliE, FiaccoA, GiuffridaD, SidoniA, CrinoL. 2012. Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations. Cancer Chemother Pharmocol, 2012Feb2[Epub ahead of print]10.1007/s00280-012-1829-7.
11.
LinCC, LaiYL, LinTC, ChenWS, JiangJK, YangSH, WangHS, LanYT, LiangWY, HsuHM, LinJK, ChangSC. 2012. Clinicopathologic features and prognostic analysis of MSI-high colon cancer. Int J Colorectal Dis, 27:277–286.
12.
BalochZW, LiVolsiVA, AsaSL, RosaiJ, MerinoMJ, RandolphG, VielhP, DeMayRM, SidawyMK, FrableWJ. 2008. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute thyroid fine-needle aspiration-state of the art conference. Diagn Cytopathol, 36:425–437.
13.
ColantaA, LinO, TafeL, GhosseinR, NafaK, MitchellT, LadanyiM, ArcilaM. 2011. BRAF mutation analysis of fine-needle aspiration biopsies of papillary thyroid carcinoma: impact on diagnosis and prognosis. Acta Cytol, 55:563–569.
14.
XingM. 2010. Prognostic utility of BRAF mutation in papillary thyroid cancer. Mol Cell Endocrinol, 28:28–32.
15.
TheoharisC, RomanS, SosaJA. 2012. The molecular diagnosis and management of thyroid neoplasms. Curr Opin Oncol, 24:35–41.
16.
SassolasG, Hafdi-NeijariZ, FerraroA, Decaussin-PetrucciM, RoussetB, Borson-ChazotF, BarboneE, BergerN, FuscoA. 2012. Oncogenic alterations in papillary thyroid cancers of young patients. Thyroid, 22:17–26.
